NCT05222919

Brief Summary

This is a single-blinded observational randomized-control trial to study the efficacy of a dietary supplement and its effect on sleep quality, recovery, and workout performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
12 days until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2022

Completed
Last Updated

June 21, 2022

Status Verified

June 1, 2022

Enrollment Period

2 months

First QC Date

January 25, 2022

Last Update Submit

June 16, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in sleep quality

    Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in sleep quality between baseline and study intervention period.

    Baseline to 8 weeks

  • Change in recovery time after a workout

    Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in workout recovery time between baseline and study intervention period.

    Baseline to 8 weeks

Study Arms (2)

Bare performance supplement

ACTIVE COMPARATOR

Dietary supplement

Dietary Supplement: Bare performance supplement

Placebo

PLACEBO COMPARATOR

Placebo

Dietary Supplement: Placebo

Interventions

Bare performance supplementDIETARY_SUPPLEMENT

dietary supplement

Bare performance supplement
PlaceboDIETARY_SUPPLEMENT

Placebo

Placebo

Eligibility Criteria

Age24 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male \& Female between 24-45 years old
  • Self-reported mild to moderate sleep issues
  • + days of physical exercise per week
  • Self-reported stressful lifestyle
  • Own a sleep tracker that can be used for the study (e.g. Oura ring, Apple Watch, FitBit, -Whoop band, or similar other devices)
  • Must be in good health (don't report any medical conditions asked in the screening questionnaire)
  • Following a stable, consistent diet regimen
  • Willing to maintain current dietary pattern, activity level, and stable body weight for the duration of the study, and refrain from any drastic lifestyle changes

You may not qualify if:

  • Severe chronic conditions including oncological conditions, psychiatric disease, or other
  • Diagnosed insomnia
  • Food intolerances/allergies that require an EpiPen
  • Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
  • Individuals that participate in another research study during the study period
  • Individuals with a history of drug, alcohol, or substance abuse
  • Individuals taking any other sleep supplements and are unwilling to stop taking those supplements for the duration of the study period
  • Individuals who have night terrors regularly
  • Individuals who regularly sleepwalk
  • Individuals who have regular bad dreams

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

Study Officials

  • Susanne Mitschke

    Citruslabs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: single-blinded observational randomized-control trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2022

First Posted

February 3, 2022

Study Start

February 15, 2022

Primary Completion

April 15, 2022

Study Completion

April 15, 2022

Last Updated

June 21, 2022

Record last verified: 2022-06

Locations